Business Description
Ambu AS
ISIN : DK0060946788
Share Class Description:
WBO:AMBU: Class BTotal Employee Number:
5,469Compare
Compare
Traded in other countries / regions
AMBU B.Denmark0MJF.UK547A.GermanyAMBU.AustriaAMBBY.USA IPO Date
2026-05-05Description
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.25 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | 0.52 | |||||
Interest Coverage | 13.63 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 9.46 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9 | |||||
3-Year EBITDA Growth Rate | 30.9 | |||||
3-Year EPS without NRI Growth Rate | 81.7 | |||||
3-Year Book Growth Rate | 10.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 22.13 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.97 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 79.16 | |||||
9-Day RSI | 67.59 | |||||
14-Day RSI | 62.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.92 | |||||
Quick Ratio | 1.73 | |||||
Cash Ratio | 0.67 | |||||
Days Inventory | 184.67 | |||||
Days Sales Outstanding | 51.89 | |||||
Days Payable | 79.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 9.4 | |||||
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | 1.64 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59.98 | |||||
Operating Margin % | 10.71 | |||||
Net Margin % | 7.82 | |||||
EBITDA Margin % | 17.25 | |||||
FCF Margin % | 6.14 | |||||
OCF Margin % | 13.88 | |||||
ROE % | 7.95 | |||||
ROA % | 6.33 | |||||
ROIC % | 8.64 | |||||
3-Year ROIIC % | -243.45 | |||||
ROC (Joel Greenblatt) % | 27.83 | |||||
ROCE % | 10.31 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 37.15 | |||||
Forward PE Ratio | 21.44 | |||||
PE Ratio without NRI | 37.15 | |||||
Shiller PE Ratio | 50.73 | |||||
Price-to-Owner-Earnings | 36.42 | |||||
PEG Ratio | 2.21 | |||||
PS Ratio | 2.9 | |||||
PB Ratio | 2.89 | |||||
Price-to-Tangible-Book | 6.36 | |||||
Price-to-Free-Cash-Flow | 47.23 | |||||
Price-to-Operating-Cash-Flow | 20.91 | |||||
EV-to-EBIT | 26.05 | |||||
EV-to-EBITDA | 16.53 | |||||
EV-to-Revenue | 2.85 | |||||
EV-to-FCF | 46.3 | |||||
Price-to-GF-Value | 0.52 | |||||
Price-to-Projected-FCF | 2.82 | |||||
Price-to-DCF (Earnings Based) | 2.72 | |||||
Price-to-DCF (FCF Based) | 3.49 | |||||
Price-to-Median-PS-Value | 0.38 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.8 | |||||
Price-to-Graham-Number | 3.24 | |||||
| Price-to-Net-Current-Asset-Value | 11.71 | |||||
Earnings Yield (Greenblatt) % | 3.84 | |||||
FCF Yield % | 2.14 | |||||
Forward Rate of Return (Yacktman) % | 20.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ambu AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 817.478 | ||
| EPS (TTM) (€) | 0.241 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 62.02 | ||
| 14-Day ATR (€) | 0.197898 | ||
| 20-Day SMA (€) | 8.4245 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 7.635 - 9.28 | ||
| Shares Outstanding (Mil) | 263.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ambu AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ambu AS Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-02 | In 151 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-11-05 11:00 | In 125 days | ||
| Annual report for 2026 | 2026-11-05 | In 124 days | ||
| Fourth quarter earnings results for 2026 | 2026-11-05 | In 124 days | ||
| Third quarter earnings conference call for 2026 | 2026-08-26 | In 53 days | ||
| Third quarter earnings results for 2026 | 2026-08-26 | In 53 days | ||
| Second quarter earnings conference call for 2026 | 2026-05-06 11:00 | 8.36 (-7.83%) | ||
| Second quarter earnings results for 2026 | 2026-05-06 07:00 | 8.36 (-7.83%) | ||
| First quarter earnings conference call for 2026 | 2026-02-04 10:00 | -- | ||
| First quarter earnings results for 2026 | 2026-02-04 | -- |
Show
Entries
Ambu AS Frequently Asked Questions
What is Ambu AS(WBO:AMBU)'s stock price today?
The current price of WBO:AMBU is €8.90. The 52 week high of WBO:AMBU is €9.28 and 52 week low is €7.64.
When is next earnings date of Ambu AS(WBO:AMBU)?
The next earnings date of Ambu AS(WBO:AMBU) is 2026-08-26.
Does Ambu AS(WBO:AMBU) pay dividends? If so, how much?
Ambu AS(WBO:AMBU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Ambu AS
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers